ACAD vs ECL
ACADIA Pharmaceuticals Inc (ACAD) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported ACAD revenue for 2024-12-31 was $957.8M. Net income was $226.5M. Revenue was up 314.6% from 2023-12-31 to 2024-12-31. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the ACAD and ECL stock pages for the full models.
Not investment advice.